Vaccines
Fri 04-Jan-2008 14:56
Herpes vaccines are currently being investigated and it is felt that an effective vaccine may be available in 3-5 years. Vaccines will only function to prevent the infection in new patients. Those who already have the simplex virus disease will probably not gain any benefit. Some vaccines have been tried to prevent the HSV occurrence, but so far had no noticible effects. These include the smallpox, Polio and Lupidon C vaccine. GlaxoSmithKline Biologicals announced the launch of their phase III trial, called the ˇ°HERPEVAC Trial for Womenˇ±, which began in November 2002. Isoniplex (Isoprinosine) is already available in over 56 countries. Most countries have approved it for use in HSV infections due to its antiviral action, and more significantly, the ability to stimulate the body's immune response. Isoniplex is currently under investigational trials for HSV primary and recurrent cases in the United States.